-+ 0.00%
-+ 0.00%
-+ 0.00%

Citigroup Initiates Coverage On Alnylam Pharmaceuticals with Buy Rating, Announces Price Target of $380

Benzinga·05/19/2026 14:33:54
Listen to the news
Citigroup analyst Eric Joseph initiates coverage on Alnylam Pharmaceuticals (NASDAQ:ALNY) with a Buy rating and announces Price Target of $380.